logo
Plus   Neg
Share
Email

Airbus Finalises DoI With A400M Launch Customer Nations

Airbus SE (EADSF.PK) announced that it has signed a Declaration of Intent with the A400M Launch Customer Nations, Germany, France, United Kingdom, Spain, Turkey, Belgium, Luxemburg, defining the framework for mutually binding contract amendment in
2018.

Tom Enders, Chief Executive Officer of Airbus, stated, "This agreement with our customers is an important step to further mitigate risks remaining on the A400M programme."

Enders added, "However, since its inception in 2003, this programme has
suffered not only from a number of operational issues but, more importantly,
under a flawed contractual set-up and insufficient budget which resulted in
significant losses for Airbus as prime contractor. We have a good chance to
stop or at least reduce the bleeding now and deliver the capabilities our
customers need,"

Airbus, European defence agency OCCAR and the seven countries have agreed
to work on several contractual elements, including a revamped delivery plan, a roadmap for the development and completion of military capabilities for the A400M.

Airbus noted that an increase to the Loss Making Contract provision on the programme, which may be material, is under assessment for the full year 2017 results which
will be disclosed on February 15, 2018. The company has recorded a total charge of EUR 2.2 billion in 2016 due to A400M programme exposure.

by RTTNews Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Editors Pick
Nvidia Corp. (NVDA) Thursday reported a surge in its second-quarter profit, driven largely by a better-than-expected growth in revenues and strong margins. However, shares of the graphics chip maker slipped about 4 percent in extended session, as its revenue outlook for the current quarter fell short... The U.S. Food and Drug Administration Thursday approved the first generic version of Mylan's EpiPen for the emergency treatment of allergic reactions. Teva Pharmaceuticals gained the US regulator's approval to market its generic epinephrine auto-injector in 0.3 mg and 0.15 mg strengths. Shares of... Amazon.com Inc. (AMZN) is reportedly planning to acquire Landmark Theatres, as the e-commerce giant seeks to gain a foothold in the brick-and-mortar cinema industry. Bloomberg Thursday reported, citing people familiar with the situation, that Amazon is looking with other suitors to acquire the business...
Follow RTT